D. Boral ARC Acquisition I Corp. 8K

BCAR shareholders approved the business combination with Exascale Labs, leaving about $12 million in the SPAC trust and clearing the way for the combined company, Exascale Labs Holdings Inc., to list on Nasdaq as XLAB and XLABW.

On July 29, 2026, Exascale Labs Inc. and D. Boral ARC Acquisition I Corp. announced that BCAR’s shareholders, at an Extraordinary General Meeting held the same day, approved their previously announced business combination and all related proposals, paving the way for the transaction to close shortly, subject to remaining conditions. Following shareholder redemptions, approximately $12 million remains in BCAR’s trust account—an amount that satisfies the minimum cash closing condition and, net of transaction expenses, will be available to the combined company at closing. Upon completion of the business combination, the combined entity is expected to operate as Exascale Labs Holdings Inc., with its Class A common stock and warrants trading on Nasdaq under the ticker symbols “XLAB” and “XLABW,” respectively, and the parties currently do not anticipate seeking additional financing before closing.

Filing Facts

CIK

2065779

Ticker

-

Form

8K

Source Type

sec

Accession

0001829126-26-008043

Alert Tier

8